Clinical trial
A Randomized Controlled Study of Hysteroscopic "360°" Surgery for Improvement of Symptoms in Cesarean Scar Defects
NCT06917014 is registered in ClinicalTrials.gov with Fu Xing Hospital, Capital Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Study of Hysteroscopic "360°" Surgery for Improvement of Symptoms in Cesarean Scar Defects
- Lead sponsor
- Fu Xing Hospital, Capital Medical University
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- May 16, 2025
- Completion date
- November 30, 2029
- Enrollment
- 88 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
cesarean scar defect